These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

680 related articles for article (PubMed ID: 33436433)

  • 1. Peptide-Conjugated Phosphorodiamidate Morpholino Oligomers Retain Activity against Multidrug-Resistant Pseudomonas aeruginosa
    Moustafa DA; Wu AW; Zamora D; Daly SM; Sturge CR; Pybus C; Geller BL; Goldberg JB; Greenberg DE
    mBio; 2021 Jan; 12(1):. PubMed ID: 33436433
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of Pseudomonas aeruginosa by Peptide-Conjugated Phosphorodiamidate Morpholino Oligomers.
    Howard JJ; Sturge CR; Moustafa DA; Daly SM; Marshall-Batty KR; Felder CF; Zamora D; Yabe-Gill M; Labandeira-Rey M; Bailey SM; Wong M; Goldberg JB; Geller BL; Greenberg DE
    Antimicrob Agents Chemother; 2017 Apr; 61(4):. PubMed ID: 28137807
    [No Abstract]   [Full Text] [Related]  

  • 3. MCR-1 Inhibition with Peptide-Conjugated Phosphorodiamidate Morpholino Oligomers Restores Sensitivity to Polymyxin in
    Daly SM; Sturge CR; Felder-Scott CF; Geller BL; Greenberg DE
    mBio; 2017 Nov; 8(6):. PubMed ID: 29114023
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Morpholino oligomers tested in vitro, in biofilm and in vivo against multidrug-resistant Klebsiella pneumoniae.
    Geller BL; Li L; Martinez F; Sully E; Sturge CR; Daly SM; Pybus C; Greenberg DE
    J Antimicrob Chemother; 2018 Jun; 73(6):1611-1619. PubMed ID: 29506074
    [TBL] [Abstract][Full Text] [Related]  

  • 5. AcrAB-TolC Inhibition by Peptide-Conjugated Phosphorodiamidate Morpholino Oligomers Restores Antibiotic Activity
    Sturge CR; Felder-Scott CF; Pifer R; Pybus C; Jain R; Geller BL; Greenberg DE
    ACS Infect Dis; 2019 Aug; 5(8):1446-1455. PubMed ID: 31119935
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sequence specificity defines the effectiveness of PPMOs targeting
    Nanayakkara AK; Moustafa DA; Pifer R; Goldberg JB; Greenberg DE
    Antimicrob Agents Chemother; 2023 Sep; 67(9):e0024523. PubMed ID: 37610213
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antisense Inhibitors Retain Activity in Pulmonary Models of Burkholderia Infection.
    Daly SM; Sturge CR; Marshall-Batty KR; Felder-Scott CF; Jain R; Geller BL; Greenberg DE
    ACS Infect Dis; 2018 May; 4(5):806-814. PubMed ID: 29461800
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antisense phosphorodiamidate morpholino oligomers targeted to an essential gene inhibit Burkholderia cepacia complex.
    Greenberg DE; Marshall-Batty KR; Brinster LR; Zarember KA; Shaw PA; Mellbye BL; Iversen PL; Holland SM; Geller BL
    J Infect Dis; 2010 Jun; 201(12):1822-30. PubMed ID: 20438352
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of Aerosolized Rifaximin versus Tobramycin for Treatment of Pseudomonas aeruginosa Pneumonia in Mice.
    Kirby BD; Al Ahmar R; Withers TR; Valentine ME; Valentovic M; Long TE; Gaskins JR; Yu HD
    Antimicrob Agents Chemother; 2019 Jul; 63(7):. PubMed ID: 31010865
    [No Abstract]   [Full Text] [Related]  

  • 10. Phenotypic and Genotypic Adaptations in Pseudomonas aeruginosa Biofilms following Long-Term Exposure to an Alginate Oligomer Therapy.
    Oakley JL; Weiser R; Powell LC; Forton J; Mahenthiralingam E; Rye PD; Hill KE; Thomas DW; Pritchard MF
    mSphere; 2021 Jan; 6(1):. PubMed ID: 33472983
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gene-silencing antisense oligomers inhibit acinetobacter growth in vitro and in vivo.
    Geller BL; Marshall-Batty K; Schnell FJ; McKnight MM; Iversen PL; Greenberg DE
    J Infect Dis; 2013 Nov; 208(10):1553-60. PubMed ID: 24130069
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Does ivacaftor interfere with the antimicrobial activity of commonly used antibiotics against Pseudomonas aeruginosa?-Results of an in vitro study.
    Millar BC; Rendall JC; Downey DG; Moore JE
    J Clin Pharm Ther; 2018 Dec; 43(6):836-843. PubMed ID: 29959786
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synergistic Activity of Repurposed Peptide Drug Glatiramer Acetate with Tobramycin against Cystic Fibrosis Pseudomonas aeruginosa.
    Murphy RA; Coates M; Thrane S; Sabnis A; Harrison J; Schelenz S; Edwards AM; Vorup-Jensen T; Davies JC
    Microbiol Spectr; 2022 Aug; 10(4):e0081322. PubMed ID: 35727066
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peptide conjugated phosphorodiamidate morpholino oligomers increase survival of mice challenged with Ames Bacillus anthracis.
    Panchal RG; Geller BL; Mellbye B; Lane D; Iversen PL; Bavari S
    Nucleic Acid Ther; 2012 Oct; 22(5):316-22. PubMed ID: 22978365
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PEGylation of Tobramycin Improves Mucus Penetration and Antimicrobial Activity against Pseudomonas aeruginosa Biofilms in Vitro.
    Bahamondez-Canas TF; Zhang H; Tewes F; Leal J; Smyth HDC
    Mol Pharm; 2018 Apr; 15(4):1643-1652. PubMed ID: 29514003
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synergistic Activity of Berberine with Azithromycin against Pseudomonas Aeruginosa Isolated from Patients with Cystic Fibrosis of Lung In Vitro and In Vivo.
    Li Y; Huang J; Li L; Liu L
    Cell Physiol Biochem; 2017; 42(4):1657-1669. PubMed ID: 28738346
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synergistic effects of inhaled aztreonam plus tobramycin on hypermutable cystic fibrosis Pseudomonas aeruginosa isolates in a dynamic biofilm model evaluated by mechanism-based modelling and whole genome sequencing.
    Breen SKJ; Harper M; López-Causapé C; Rogers KE; Tait JR; Smallman TR; Lang Y; Lee WL; Zhou J; Zhang Y; Bulitta JB; Nation RL; Oliver A; Boyce JD; Landersdorfer CB
    Int J Antimicrob Agents; 2024 Jun; 63(6):107161. PubMed ID: 38561094
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Colistin-tobramycin combinations are superior to monotherapy concerning the killing of biofilm Pseudomonas aeruginosa.
    Herrmann G; Yang L; Wu H; Song Z; Wang H; Høiby N; Ulrich M; Molin S; Riethmüller J; Döring G
    J Infect Dis; 2010 Nov; 202(10):1585-92. PubMed ID: 20942647
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Variations in amino acid composition of antisense peptide-phosphorodiamidate morpholino oligomer affect potency against Escherichia coli in vitro and in vivo.
    Mellbye BL; Puckett SE; Tilley LD; Iversen PL; Geller BL
    Antimicrob Agents Chemother; 2009 Feb; 53(2):525-30. PubMed ID: 19015356
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of artificial sputum medium to test antibiotic efficacy against Pseudomonas aeruginosa in conditions more relevant to the cystic fibrosis lung.
    Kirchner S; Fothergill JL; Wright EA; James CE; Mowat E; Winstanley C
    J Vis Exp; 2012 Jun; (64):e3857. PubMed ID: 22711026
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.